QI is advancing the development of ASL-based classifiers designed for the diagnosis, stratification, and monitoring of Alzheimer’s disease (AD).

Leveraging data from the ADNI3 study, QI’s ASL classifiers demonstrate gold-standard performance in distinguishing mild cognitive impairment (MCI) from AD and excel in predicting the progression from MCI to AD.